Skip to content

Author

G. Aguilar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension

Right ventricular (RV) failure is the principal determinant of prognosis in pulmonary arterial hypertension (PAH). While current therapies primarily target pulmonary vasoconstriction and vascular remodeling, no treatment directly addresses RV maladaptation. Sodium–glucose cotransporter-2 (SGLT2) inhibitors exert...

C. Real, I. García-Lunar, E. Sandoval et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.